HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

Autor: Yukio Takeshita, Hikoaki Fukaura, Noriko Isobe, Yuko Shimizu, Shoji Tsuji, Katsuhisa Masaki, Kazuhide Ochi, Shin Hisahara, Ryuichi Sakate, Mitsuru Watanabe, Takuya Matsushita, Makoto Matsui, Takahiro Iizuka, Jun Ichi Kira, Susumu Kusunoki, Yuri Nakamura, Ayako Sakoda, Akio Suzumura, Etsuji Saji, Kazumasa Okada, Masanori Mizuno, Tomonori Kimura, Hirofumi Ochi, Kazutoshi Nishiyama, Takashi Kanda, Akiko Nagaishi, Shinya Sato, Masami Tanaka, Tatsusada Okuno, Masaaki Niino, Takanori Yokota, Fumie Hayashi, Izumi Kawachi, Yoichiro Nishida, Ken Yamamoto, Katsuichi Miyamoto, Makoto Hirata, Yuji Nakatsuji, Takashi Ohashi, Shigemi Nagayama, Shun Shimohama, Yuji Kawano, Koji Shinoda
Rok vydání: 2021
Předmět:
Adult
Male
musculoskeletal diseases
0301 basic medicine
medicine.medical_specialty
Multiple Sclerosis
Genotype
Science
Neuroimmunology
Human leukocyte antigen
Gastroenterology
Article
03 medical and health sciences
0302 clinical medicine
Japan
immune system diseases
Internal medicine
medicine
Humans
Optic neuritis
skin and connective tissue diseases
Genetic Association Studies
HLA-DP beta-Chains
Genetic association study
Biological Specimen Banks
Multidisciplinary
business.industry
Multiple sclerosis
Neuromyelitis Optica
Case-control study
Middle Aged
medicine.disease
Spinal cord
Phenotype
030104 developmental biology
medicine.anatomical_structure
Neurology
Neuromyelitis Optica Spectrum Disorders
Case-Control Studies
Medicine
Female
Brainstem
business
030217 neurology & neurosurgery
HLA-DRB1 Chains
Zdroj: Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Scientific Reports
ISSN: 2045-2322
Popis: HLA genotype-clinical phenotype correlations are not established for multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). We studied HLA-DRB1/DPB1 genotype–phenotype correlations in 528 MS and 165 NMOSD cases using Japan MS/NMOSD Biobank materials. HLA-DRB1*04:05, DRB1*15:01 and DPB1*03:01 correlated with MS susceptibility and DRB1*01:01, DRB1*09:01, DRB1*13:02 and DPB1*04:01 were protective against MS. HLA-DRB1*15:01 was associated with increased optic neuritis and cerebellar involvement and worsened visual and pyramidal functional scale (FS) scores, resulting in higher progression index values. HLA-DRB1*04:05 was associated with younger onset age, high visual FS scores, and a high tendency to develop optic neuritis. HLA-DPB1*03:01 increased brainstem and cerebellar FS scores. By contrast, HLA-DRB1*01:01 decreased spinal cord involvement and sensory FS scores, HLA-DRB1*09:01 decreased annualized relapse rate, brainstem involvement and bowel and bladder FS scores, and HLA-DRB1*13:02 decreased spinal cord and brainstem involvement. In NMOSD, HLA-DRB1*08:02 and DPB1*05:01 were associated with susceptibility and DRB1*09:01 was protective. Multivariable analysis revealed old onset age, long disease duration, and many relapses as independent disability risks in both MS and NMOSD, and HLA-DRB1*15:01 as an independent risk only in MS. Therefore, both susceptibility and protective alleles can influence the clinical manifestations in MS, while such genotype–phenotype correlations are unclear in NMOSD.
Databáze: OpenAIRE